Philip R Johnson, Jr

Title: The Innovations of Philip R Johnson, Jr.

Introduction

Philip R Johnson, Jr. is a notable inventor based in Wynnewood, PA (US). He has made significant contributions to the field of recombinant adeno-associated virus production, holding a total of 5 patents. His work has advanced the understanding and methodologies surrounding viral production, which is crucial for various medical applications.

Latest Patents

Johnson's latest patents include innovative methods for producing recombinant adeno-associated viruses. One of his key inventions focuses on the use of recombinant adenovirus encoding adeno-associated virus protein in production methods. This invention enhances the efficiency of producing recombinant adeno-associated viruses. Another significant patent involves the use of Simian Adenovirus 13 (SAdV-13) and Vero cells for the production of recombinant adeno-associated virus (rAAV). These advancements are vital for improving viral vector production in gene therapy.

Career Highlights

Throughout his career, Johnson has worked with esteemed institutions such as Nationwide Children's Hospital, Inc. and Children's Hospital. His experience in these organizations has allowed him to collaborate with leading experts in the field, furthering his research and innovations.

Collaborations

Some of his notable coworkers include Kelly Reed Clark and Clifford J Beall. Their collaborative efforts have contributed to the success of various projects and patents in the realm of viral production.

Conclusion

Philip R Johnson, Jr. is a distinguished inventor whose work in recombinant adeno-associated virus production has made a significant impact in the field. His patents and collaborations reflect his dedication to advancing medical science and technology.